Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (1241-1250 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|May 2, 2022
Silent Mutations Reveal a Novel Treatment for RASQ61 Cancers
Cancer Discovery|May 2, 2022
Top COVID-19 Prognostic Factors Identified
Cancer Discovery|September 22, 2021
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated FibroblastsErin J Helms, Mark W Berry, R Crystal Chaw, et al.
Cancer Discovery|April 12, 2022
Testing New Neoadjuvant Combos in NSCLC
Cancer Discovery|May 18, 2018
Explaining Resistance to CAR T Cells
Cancer Discovery|December 12, 2023
Precision Oncology: 2023 in ReviewYonina R Murciano-Goroff, Sarah P Suehnholz, Alexander Drilon, et al.
Cancer Discovery|December 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug DevelopmentJoshua M Donaldson, Marjilla Seddiq, Michael J Fusco, et al.
Cancer Discovery|December 11, 2023
ImmunoGen Takeover Caps Year of Record ADC Investments
Cancer Discovery|December 1, 2023
The Extracellular Matrix Dictates Regional Differences in Tumor Initiation
Cancer Discovery|November 30, 2023
FDA Investigating CAR-Related T-cell Malignancies
Pageof 427

Showing results (1241-1250 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|May 2, 2022
Silent Mutations Reveal a Novel Treatment for RASQ61 Cancers
Cancer Discovery|May 2, 2022
Top COVID-19 Prognostic Factors Identified
Cancer Discovery|September 22, 2021
Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated FibroblastsErin J Helms, Mark W Berry, R Crystal Chaw, et al.
Cancer Discovery|April 12, 2022
Testing New Neoadjuvant Combos in NSCLC
Cancer Discovery|May 18, 2018
Explaining Resistance to CAR T Cells
Cancer Discovery|December 12, 2023
Precision Oncology: 2023 in ReviewYonina R Murciano-Goroff, Sarah P Suehnholz, Alexander Drilon, et al.
Cancer Discovery|December 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug DevelopmentJoshua M Donaldson, Marjilla Seddiq, Michael J Fusco, et al.
Cancer Discovery|December 11, 2023
ImmunoGen Takeover Caps Year of Record ADC Investments
Cancer Discovery|December 1, 2023
The Extracellular Matrix Dictates Regional Differences in Tumor Initiation
Cancer Discovery|November 30, 2023
FDA Investigating CAR-Related T-cell Malignancies
Pageof 427